Statin Use May Benefit Patients Hospitalized With COVID-19
The use of statins appears to benefit patients hospitalized with COVID-19, according to the findings of a retrospective study conducted in Hubei Province, China.
All articles by Cassandra Pardini, PharmD
Supplements With Undeclared Active Ingredients Pose Substantial Health Risk
A recent Morbidity and Mortality Weekly Report (MMWR) highlights the risks associated with use of over-the-counter (OTC) products containing undeclared prescription ingredients as well as the importance of collaboration between various health departments and systems to ensure a prompt response to an outbreak.
Clinical Benefit Observed With Colchicine in Hospitalized COVID-19 Patients
The open-label, prospective study (GRECCO-19) assessed the effect of treatment with low-dose colchicine on cardiac and inflammatory biomarkers as well as clinical outcomes.
Adherence to BP Meds Linked to Improved Survival in Frail Elderly Patients
Adherence to antihypertensive treatment was associated with a reduced risk of death among elderly patients, including frail individuals, according to a large study published in Hypertension.
Risk of Hypersensitivity Reactions Assessed With Commonly Used Gout Treatments
Allopurinol and febuxostat were found to be associated with a higher risk of hypersensitivity reactions when compared to colchicine, according to the results of a recently published population-based study.
UTI Recurrence in Pediatric Patients: Antibiotic Treatment Duration Examined
Several factors were associated with an increased risk of UTI recurrence. These included antibiotic exposure prior to treatment, pyelonephritis on diagnosis date, having a follow-up visit during antibiotic treatment, receiving parenteral antibiotics.
Review: Areas of Pediatric Medical Overuse Identified
A recent systematic review identified several established as well as emerging practices utilized in the pediatric setting that were associated with overuse of medical care.
Study IDs Meds Commonly Used in Primary Care That Should Be Dose Adjusted, Avoided in CKD
A list of medications routinely prescribed in primary care practice that should be used cautiously or avoided in patients with chronic kidney disease (CKD) was compiled in a recently published study in the Annals of Pharmacotherapy.
Risk of Acute Kidney Injury With SGLT2 Inhibitors Investigated
Sodium-glucose cotransporter-2 inhibitors (SGLT2is) do not appear to increase the risk of acute kidney injury (AKI), according to the findings of a recently published systematic review and meta-analysis. To evaluate the risk of AKI with these agents, study authors reviewed literature analyzing the effect of SGLT2is on renal adverse events compared with placebo or other…
Corticosteroids Compared for Pre-Infusion Prophylaxis in Patients Receiving Pegloticase for Gout
Compared with intravenous hydrocortisone, IV methylprednisolone appears to be more beneficial as a pre-infusion prophylaxis therapy in patients receiving pegloticase, according to the findings of a recently published review.
-
Loading...
-
Loading...
Next post in Hyperuricemia
